nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide

C184H148F6Ir9N28-18 — CID 157315789

About nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide

nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide (PubChem CID 157315789) has the molecular formula C184H148F6Ir9N28-18 and a molecular weight of 4595.34 g/mol. Its IUPAC name is nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide.

Molecular Properties

• Compound Name: nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide
• PubChem CID: 157315789
• Molecular Formula: C184H148F6Ir9N28-18
• Molecular Weight: 4595.34 g/mol
• Exact Mass: 4599.91
• IUPAC Name: nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide
• SMILES: CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.Cc1c(-c2ccccc2)cccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccc(C(F)(F)F)c21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccc(C(F)(F)F)c21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir]
• InChI: InChI=1S/C25H19N3.C21H15F3N2.2C21H19N3.C20H14F3N3.C20H18N4.2C19H15N3.C18H14N4.9Ir/c1-19-22(20-10-4-2-5-11-20)14-8-15-23(19)28-18-27(21-12-6-3-7-13-21)25-24(28)16-9-17-26-25;1-15-8-5-6-12-18(15)26-14-25(16-9-3-2-4-10-16)19-13-7-11-17(20(19)26)21(22,23)24;1-16(2)18-11-6-7-12-19(18)24-15-23(17-9-4-3-5-10-17)21-20(24)13-8-14-22-21;1-16(2)18-11-6-7-12-19(18)24-15-23(17-9-4-3-5-10-17)20-13-8-14-22-21(20)24;1-14-7-5-6-10-17(14)26-13-25(15-8-3-2-4-9-15)19-18(26)16(11-12-24-19)20(21,22)23;1-15(2)17-10-6-7-11-18(17)24-14-23(16-8-4-3-5-9-16)19-20(24)22-13-12-21-19;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)19-18(22)12-7-13-20-19;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;;;;;;/h2-12,14-18H,1H3;2-9,11-14H,1H3;2*3-9,11-16H,1-2H3;2-8,10-13H,1H3;3-8,10-15H,1-2H3;2*2-9,11-14H,1H3;2-8,10-13H,1H3;;;;;;;;;/q9*-2
• InChIKey: QUIDZFPVGQPJID-UHFFFAOYSA-N
• XLogP: 46.92
• TPSA: 187.22 Ų
• H-Bond Acceptors: 28
• Rotatable Bonds: 22
• Heavy Atoms: 227
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	4595.34
LogP ≤ 5	46.92
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	28

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide?

The IUPAC name of nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide (CID 157315789) is nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide.

What is the SMILES notation for nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide?

The canonical SMILES for nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide is CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.CC(C)c1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.Cc1c(-c2ccccc2)cccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccc(C(F)(F)F)c21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccc(C(F)(F)F)c21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].

What is the InChIKey of nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide?

The InChIKey is QUIDZFPVGQPJID-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H19N3.C21H15F3N2.2C21H19N3.C20H14F3N3.C20H18N4.2C19H15N3.C18H14N4.9Ir/c1-19-22(20-10-4-2-5-11-20)14-8-15-23(19)28-18-27(21-12-6-3-7-13-21)25-24(28)16-9-17-26-25;1-15-8-5-6-12-18(15)26-14-25(16-9-3-2-4-10-16)19-13-7-11-17(20(19)26)21(22,23)24;1-16(2)18-11-6-7-12-19(18)24-15-23(17-9-4-3-5-10-17)21-20(24)13-8-14-22-21;1-16(2)18-11-6-7-12-19(18)24-15-23(17-9-4-3-5-10-17)20-13-8-14-22-21(20)24;1-14-7-5-6-10-17(14)26-13-25(15-8-3-2-4-9-15)19-18(26)16(11-12-24-19)20(21,22)23;1-15(2)17-10-6-7-11-18(17)24-14-23(16-8-4-3-5-9-16)19-20(24)22-13-12-21-19;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)19-18(22)12-7-13-20-19;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;;;;;;/h2-12,14-18H,1H3;2-9,11-14H,1H3;2*3-9,11-16H,1-2H3;2-8,10-13H,1H3;3-8,10-15H,1-2H3;2*2-9,11-14H,1H3;2-8,10-13H,1H3;;;;;;;;;/q9*-2;;;;;;;;;.

What are the key properties of nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide?

nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide has a molecular weight of 4595.34 g/mol, XLogP of 46.92, 22 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.

Where does this data come from?

All data for nonakis(iridium);3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-(2-methylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-(2-methyl-3-phenylphenyl)-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;3-(2-methylphenyl)-1-phenyl-4-(trifluoromethyl)-2H-benzimidazol-2-ide;1-(2-methylphenyl)-3-phenyl-7-(trifluoromethyl)-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-propan-2-ylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide is sourced from PubChem (CID 157315789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).